LogiCare3PL and ChiRhoClin Team Up for ChiRhoStim® Distribution

LogiCare3PL Partners with ChiRhoClin, Inc.

In a significant move to improve patient care for pancreatic and gastrointestinal disorders, LogiCare3PL has announced a strategic partnership with ChiRhoClin, Inc., a recognized leader in the development of diagnostic solutions for these medical conditions. Effective from July 14, 2025, LogiCare3PL will act as the exclusive third-party logistics provider for ChiRhoStim® (Human Secretin for Injection), ChiRhoClin's flagship diagnostic product.

This collaboration marks a pivotal advancement in how ChiRhoClin is able to distribute its critical diagnostic treatments. LogiCare3PL brings extensive expertise in orphan drug logistics, which is crucial for ensuring timely and reliable access to these specialized products. According to Kevin Kissling, Vice President and General Manager of LogiCare3PL, "We're proud to support ChiRhoClin in distributing ChiRhoStim®, a diagnostic product that plays a vital role in patient care. Our commitment is to deliver a seamless and dependable experience for ChiRhoClin's customers."

LogiCare3PL operates two fully accredited distribution centers located in Tempe, Arizona, and Olive Branch, Mississippi. These centers serve as operational hubs capable of handling high-value, small-batch pharmaceutical logistics. Designed with precision and reliability in mind, both facilities maintain compliance with current Good Manufacturing Practices (cGMP) and hold accreditation from the National Association of Boards of Pharmacy (NABP). This level of accreditation underscores LogiCare3PL's commitment to the highest standards of compliance and quality.

The partnership was established following extensive preparations by both companies. Skip Purich, CEO of ChiRhoClin, expressed gratitude for the proactive collaboration with LogiCare3PL, saying, "Their experience in orphan drug logistics has been critical to establishing a strong foundation for this launch. We're confident this partnership will deliver a high level of service to our customers."

ChiRhoClin, Inc., based in Maryland, is dedicated to developing orphan drug products tailored for patients suffering from rare pancreatic and gastrointestinal diseases. The company is committed to enhancing diagnostic and therapeutic options and is actively involved in research initiatives, including their Small Pancreatic Grant Program aimed at supporting ongoing medical research.

LogiCare3PL, a division of BioCare, Inc., specializes in the distribution of orphan, specialty, and high-value pharmaceutical products. Their robust logistics solutions fulfill the unique needs of manufacturers, healthcare providers, and patients alike. In light of this partnership, both organizations are poised to make significant contributions to the healthcare landscape, particularly in the realm of rare diseases and patient-centered diagnostics.

This alliance not only symbolizes mutual commitment to quality and reliability but also illustrates a shared vision for delivering exceptional healthcare solutions. As this partnership advances, both LogiCare3PL and ChiRhoClin look forward to continuing their efforts in providing crucial support to patients nationwide.